Accuracy of an internationally validated genetic-guided warfarin dosing algorithm compared to a clinical algorithm in an Arab population
<h3>Purpose</h3><p dir="ltr">To identify the impact of <i>CYP2C9*2, *3, VKORC1−1639 G>A </i>and <i>CYP4F2*3</i> on warfarin dose in an Arab population. To compare the accuracy of a clinical warfarin dosing (CWD) versus genetic warfarin dosing al...
Saved in:
| Main Author: | Amr M. Fahmi (21632909) (author) |
|---|---|
| Other Authors: | Ahmed El Bardissy (22155949) (author), Mohamed Omar Saad (12535545) (author), Amr Fares (22155952) (author), Ahmed Sadek (4588474) (author), Mohamed Nabil Elshafei (9960500) (author), Asma Eltahir (14158923) (author), Asmaa Mohamed (19870274) (author), Hazem Elewa (3592601) (author) |
| Published: |
2024
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical versus fixed warfarin dosing and the impact on quality of anticoagulation (The ClinFix trial)
by: Amr M. Fahmi (21632909)
Published: (2024) -
Genetic Polymorphism Effect on Warfarin–Rifampin Interaction: A Case Report and Review of Literature
by: Muhammad Salem (8979428)
Published: (2021) -
Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management
by: Islam, Eljilany
Published: (2022) -
Effect of SAMe-TT<sub>2</sub>R<sub>2</sub> score and genetic polymorphism on the quality of anticoagulation control in Qatari patients treated with warfarin
by: Hazem Elewa (3592601)
Published: (2020) -
Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management
by: Islam Eljilany (14151588)
Published: (2023)